Inventor · disambiguated record
Jochen Antel
Also filed as: ANTEL JOCHEN
18 granted patents·10 pending applications·169 citations·filing 1996–2023
92Inventor score
Files withSOLVAY PHARM GMBH19ANTEL JOCHEN2UNIV DUISBURG ESSEN2FIRNGES MICHAEL1SOLVAY PHARMACEUTICAL GMBH1
Top patents by PatentIndex Score
28 records- 0191US5677297ABenzazepine-, benzoxazepine- and benzothiazepine-n-acetic acid derivatives, process for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 1996·Granted Oct 14, 1997·125 cites·14 claims
- 0282US7238470B2Method of treating or inhibiting obesitySOLVAY PHARM GMBH·Filed 2004·Granted Jul 3, 2007·9 cites·3 claims
- 0376US7763607B2Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulatorsSOLVAY PHARM GMBH·Filed 2007·Granted Jul 27, 2010·1 cites·17 claims
- 0474US6946243B2Method of identifying compounds suitable for treatment and/or prophylaxis of obesitySOLVAY PHARM GMBH·Filed 2001·Granted Sep 20, 2005·4 cites·15 claims
- 0573US7767692B21-amidomethylcarbonyl-piperidine compounds, methods and intermediate products for the production thereof and pharmaceutical formulations containing said compoundsSOLVAY PHARM GMBH·Filed 2003·Granted Aug 3, 2010·7 cites·40 claims
- 0672US7244743B2Non-peptidic BRS-3 agonistsSOLVAY PHARM GMBH·Filed 2004·Granted Jul 17, 2007·3 cites·11 claims
- 0771US7074822B2Alkyl carbamate-substituted β-lactones, process for their preparation, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2005·Granted Jul 11, 2006·2 cites·10 claims
- 0864US6770649B21-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 2002·Granted Aug 3, 2004·2 cites·12 claims
- 0963US7282325B2Method of preparing pharmaceutical compositionsSOLVAY PHARM GMBH·Filed 2004·Granted Oct 16, 2007·0 cites·2 claims
- 1061US8058264B2Pharmaceutical compositions comprising CB1 cannabinoid receptor antagonists and potassium channel openers for the treatment of obesity and related conditionsFIRNGES MICHAEL·Filed 2005·Granted Nov 15, 2011·1 cites·25 claims
- 1161US2025339497A1Methods for treating mood disorders by administering a leptin receptor agonistUNIV DUISBURG ESSEN·Filed 2023·Application pending·0 cites
- 1258US2009104126A1Sulfamate Compounds and Uses ThereofSOLVAY PHARM GMBH·Filed 2008·Application pending·0 cites
- 1358US2023080196A1Methods for treating anorexia nervosa and related conditions by administering a leptin receptor agonistUNIV DUISBURG ESSEN·Filed 2022·Application pending·0 cites
- 1455US2005124660A1Novel medical uses of compounds showing CB1-antagonistic activity and combination treatment involving said compoundsFiled 2004·Application pending·0 cites
- 1554US6930207B2Trifluoroacetylalkyl-substituted phenyl, phenol and benzoyl compounds and related methods of treatmentSOLVAY PHARMACEUTICAL GMBH·Filed 2004·Granted Aug 16, 2005·2 cites·31 claims
- 1654US2007254863A1Use of CBx cannabinoid receptor modulators as potassium channel modulatorsANTEL JOCHEN·Filed 2007·Application pending·0 cites
- 1754US2005143441A1Novel medical combination treatment of obesity involving 4,5-dihydro-1H-pyrazole derivatives having CB1-antagonistic activityFiled 2004·Application pending·0 cites
- 1854US2005239859A2Novel medical uses of 4,5-dihydro-1h-pyrazole derivatives having cb1- antagonistic activitySOLVAY PHARM GMBH·Filed 2004·Application pending·0 cites
- 1952US6001833AUrea derivativesSOLVAY PHARM GMBH·Filed 1998·Granted Dec 14, 1999·10 cites·5 claims
- 2048US7592344B2NK1 and NK2-antagonists and compositions and methods of using the sameSOLVAY PHARM GMBH·Filed 2006·Granted Sep 22, 2009·0 cites·16 claims
- 2147US2005261292A1Pharmaceutical composition containing N-sulfamoyl-N'-arylpiperazines for the treatment or inhibition of obesity and related conditionsSOLVAY PHARM GMBH·Filed 2005·Application pending·0 cites
- 2245US2005101585A1Use of selective CB1-antagonists in medical treatmentsSOLVAY PHARM GMBH·Filed 2004·Application pending·0 cites
- 2344US7772225B2N-sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditionsSOLVAY PHARM GMBH·Filed 2006·Granted Aug 10, 2010·0 cites·18 claims
- 2442US6900322B1Method for stereochemically controlled production of isomerically pure highly substituted azacyclic compoundsSOLVAY PHARM GMBH·Filed 1999·Granted May 31, 2005·3 cites·13 claims
- 2541US7547708B2N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereofSOLVAY PHARMACEUTICALS INC·Filed 2006·Granted Jun 16, 2009·0 cites·20 claims
- 2641US2007191357A1Methods of using potassium channel inhibiting compoundsANTEL JOCHEN·Filed 2006·Application pending·0 cites
- 2729US6040303A7-phenyl-1, 4-diazepane compounds, process for their preparation, and pharmaceutical compositions containing themSOLVAY PHARM GMBH·Filed 1998·Granted Mar 21, 2000·0 cites·6 claims
- 2827US5843948APiperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives, and processes and intermediates for their preparation and pharmaceutical compositions comprising themSOLVAY PHARM GMBH·Filed 1997·Granted Dec 1, 1998·0 cites·12 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →